42 results about "Prostatic Diseases" patented technology

According to an aspect of the invention, urological medical devices are provided, which comprise a prostatically beneficial agent selected from alpha-adrenergic blockers, antispasmodic agents, anticholinergic / antimuscarinic agents, calcium channel blockers, anti-inflammatory agents, hormone-affecting agents, anti-cancer agents, and combinations thereof, among others. The urological medical devices are adapted for implantation or insertion into a subject's urinary tract, whereupon at least a portion of the prostatically beneficial agent is released into the subject's prostatic urethra. The release profile of the prostatically beneficial agent is effective to treat a prostatic disorder, for example, benign prostate hypertrophy, prostate cancer or prostatitis, among others. Other aspects of the invention are directed to treating prostatic disorders.

The invention provides therapeutic methods for inhibiting, ameliorating or alleviating the hyperproliferative cellular activity of diseases of the prostate, e.g., prostatic cancer and prostatic hyperplasia, which includes administering to a patient in need thereof an active vitamin D analogue and another anticancer agent. Cell differentiation is promoted, induced or enhanced without causing to the patient dose-limiting hypercalcemia and hypercalciuria.

The invention discloses a maca tablet capable of treating and improving prostatic diseases and a preparation method thereof. The maca tablet comprises the following basic ingredients in proportion: 30 percent of maca essence, 20 percent of maca residual powder, and 50 percent of starch. The preparation method comprises the following steps: cleaning, airing and crushing maca; gelatinizing the maca; crushing the gelatinized maca by an ultrasonic spray crushing method, and extracting with 95 percent edible alcohol which serves as an extract to prepare the maca essence; extracting 2-3 times, and mixing the essences; drying maca residues which are subjected to essence extract, and screening through a 100-mesh screen; screening starch through the 100-mesh screen; mixing the materials in a mixer according to the ingredient proportion to prepare a soft material; pelleting the soft material in a oscillating granulator, and crushing and granulating by use of a 20-mesh screen; drying wet grains in an air dry oven at 60 DEG C; reducing the moisture of the grains to 1-3%; and adding magnesium stearate serving as a lubricant into dry grains, uniformly mixing, tabletting, coating with membranes, radiating for 30 minutes under ultraviolet ray for sterilization, and packaging to obtain a finished product.

A multi-point urethra temp monitoring catheter for the thermal fusion therapy of prostatic diseases is composed of a dual-cavity or three-cavity catheter, the temp sensors with head end on the surface and tail end led out from the cavity of catheter, and the thermoelectric compensating line with one end connected to the tail end of said temp sensors.

A photothermal therapeutic apparatus for treating prostatic diseases is composed of power supply system, laser system consisting of relay, power supply and laser device, computer control system, thermal radiation circuit, cables and therapeutic probe consisting of laser output window, temp sensor, thermal radiator, jacket and handle. Its advantages are high curative effect, no by-effect, compact structure and high stability.

A Chinese medicine for treating prostatic diseases is prepared from 12 Chinese-medicinal materials including dandelion herb, tree peony root, motherwort, astragalus root, etc through decocting 5 of them, filtering, concentrating, mixing the pulverized others and preparing pills.

The invention provides a medicine for adjunctively treating prostatic diseases, which is a medicament prepared from the following raw materials and pharmaceutically acceptable auxiliary materials in parts by weight: 160-260 parts of sabal extracts, 25-72 parts of pygeum topengii extracts, 20-80 parts of pumpkinseed extracts, 3-20 parts of lycopene and 2-15 parts of zinc. The medicine is used for treating the prostatic diseases by taking the sabal extracts and the pygeum topengii extracts as main raw materials; the synergistic effect is enhanced through the pumpkinseed extracts to play an important role in enhancing the bioavailability of the effectively components of the sabal extracts; the antioxidant ability of organisms and the resistance can be enhanced through the lycopene; and the risks of prostatic cancers is reduced by preventing and improving the prostatic diseases through the lycopene and the zinc; the medicine provided by the invention accords with the traditional Chinese medicine theory and has more scientific formula and more outstanding effect; through clinical verification, the medicine has better curative effect on the prostatic diseases; in addition, the medicine provided by the invention can be taken for a long time without toxic side effect and has the effects of disease prevention and treatment.

The externally applied medicine powder for treating prostatic diseases is prepared with prepared pangolin scales, honey locust spine, cowherb seed, rhubarb, dandelion and other Chinese medicinal materials, and through sorting material, washing, stoving and crushing. The externally applied medicine powder is acted onto prostate through external application. The externally applied medicine powder has the functions of dispersing blood clots, eliminating turbid substance, softening the dry feces, dissipating mass, resisting inflammation and dredging meridian, etc. and is used in treating prostatitis, seminal vesicle inflammation, prostate proliferation, seminal vesicle proliferation and other diseases of prostate and seminal vesicle.

The quick-acting prostate pill for treating prostatic diseases is prepared with prepared tortoise plastron, dodder seed, Korean raspberry, mantis egg case, malaytea scurfpea fruit and other Chinese medicinal materials, and through sorting material, washing, stoving, decocting, crushing, making pill, sterilizing and other steps. The quick-acting prostate pill has the functions of invigorating kidney, replenishing essence, nourishing prostate, resisting inflammation, dredging meridian, etc. and is used in treating prostatitis, seminal vesicle inflammation, prostate proliferation, seminal vesicle proliferation and other diseases of prostate and seminal vesicle.

The invention discloses an ultrasonic treatment unit for prostatic diseases, which comprises a spherical crown body, an ultrasonic probe arranged at the bottom of the spherical crown body, an installation base, a spherical crown body support, a spherical crown body support lifting mechanism, a spherical crown body support rotating mechanism, a spherical crown body swing mechanism and an ultrasonic probe lifting mechanism, wherein the spherical crown body support lifting mechanism is installed on the installation base, the spherical crown body support and the spherical crown body support rotating mechanism are installed on the spherical crown body support lifting mechanism, and the spherical crown body swing mechanism and the ultrasonic probe lifting mechanism are installed on the spherical crown body support. Through the linkage of the spherical crown body support lifting mechanism, the spherical crown body support rotating mechanism, the spherical crown body swing mechanism and a spherical crown body rotary mechanism, the spherical domain of the spherical crown body of the ultrasonic treatment unit for prostatic diseases is realized. The invention has the advantages that the structure is compact, the occupied area is small and great progress is made in the ultrasonic treatment unit for prostatic diseases.

The invention provides application of ailanthone (AIL) which is shown in a formula (I) and is a monomer of Chinese traditional herbs to preparation of medicines for treating prostatic disease. By a compound, in-vitro and / or in-vivo growth and migration of prostate carcinoma cells can be suppressed obviously, protein expression level of an androgen receptor in the prostate carcinoma cells is reduced, and a signal path of the androgen receptor is suppressed. The compound has a prostate cancer treatment application prospect.

The invention discloses traditional Chinese medicine health-preserving liquid which is prepared from the following extracting solutions of raw materials in part by mass: 15-25 parts of ginseng, 5-10 parts of cordyceps militaris, 5-10 parts of medlar, 10-20 parts of maca powder, 5-10 parts of rhizoma polygonati, 10-20 parts of oyster, 5-10 parts of grape seeds, 5-10 parts of agaricus blazei murill,5-10 parts of abelmoschus esculentus, 5-10 parts of algae and 500-1000 parts of water. The traditional Chinese medicine health-preserving liquid disclosed by the invention has the effects of relieving fatigue, enhancing immunity, invigorating kidney and strengthening Yang, refreshing and regulating sleep and has a certain therapeutic effect on prostatic disease and back pain.

According to an aspect of the invention, urological medical devices are provided, which comprise a prostatically beneficial agent selected from alpha-adrenergic blockers, antispasmodic agents, anticholinergic / antimuscarinic agents, calcium channel blockers, anti-inflammatory agents, hormone affecting agents, anti-cancer agents, and combinations thereof, among others. The urological medical devices are adapted for implantation or insertion into a subject's urinary tract, whereupon at least a portion of the prostatically beneficial agent is released into the subject's prostatic urethra. The release profile of the prostatically beneficial agent is effective to treat a prostatic disorder, for example, benign prostate hypertrophy, prostate cancer or prostatitis, among others. Other aspects of the invention are directed to treating prostatic disorders.

A selenium-contained lily bulb-Taihe chicken sausage for improving immunity, treating gynopathy and prostatic disease, and balancing functions is prepared from dried lily bulb, Taihe chicken and mildewed tea through preparing stuffing and filling it in the casing for sausage.

The invention relates to the technical field of medicine, and relates to a phytosterol extract prepared with a soybean deodorized distillate as a raw material. Animal experiments prove that the phytosterol extract has the effects of prevention and treatment of prostatitis, prostatic hyperplasia, prostatic hypertrophy and other related diseases, and can be used for preparation of drugs and food for prevention and treatment of prostatitis, prostatic hyperplasia and prostatic hypertrophy and other related diseases.

The invention provides a medicine for treating prostatic diseases. The medicine for treating the prostatic diseases consists of the following components in parts by weight: 5-15 parts of rheum officinale, 15-25 parts of Yoyumin, 15-25 parts of saururus chinensis, 15-25 parts of garden burnet, 55-65 parts of phaseolus calcaratus, 15-25 parts of poria cocos and 15-25 parts of oldenlandia diffusa. The medicine for treating the prostatic diseases has effects of clearing heat and removing toxicity, promoting diuresis and dispelling dampness, disperse swelling and removing stasis, is good in treatment effect on symptoms, such as urinary system infection, cystolith, hematuresis, urgent urination, frequent urination, dysuria, aversion to cold, fever, weakness and perineal superior region, suprapubic region, inguinal region and genital organ pain and discomfort caused by prostatitis and prostatic hyperplasia, has a remarkable treatment effect with high recovery speed, low recurrence rate, high safety and no side effect, and is simple and convenient in preparation.

The present invention relates to a Chinese medicine for curing acute and chronic prostatic diseases and its preparation process. Its raw material composition includes 9 Chinese medicinal materials of (by weight portion) 3-15 portions of fish poison yam, 1-8 portions of puccoon, 1-6 portions of gleditsia thorn, 1-6 portions of achyranthes root, 3-10 portions of plantago, 3-10 portions of dried / fresh rehmannia root, 3-10 portions of astragalus root, 1-5 portions of prepared corydalis tuber and 1-6 portions of Eastern phellodendron bark. Said Chinese medicine can be made up by using above-mentioned raw materials through a certain preparation process, and has obvious effect for inhibiting and curing bacterial and nonbacterial prostatitises, at the same time has the actions of resisting inflammation and stopping pain.

The present invention relates to a method capable of using natural and artificial synthetic isosulfocyanate compound or its derivative to prevent and cure prostatic diseases and skin carcinoma. The internal tests show that various isosulfocyanate compounds or their derivatives can induce prostatic cell II phase drug metabolic detoxication enzyme-glutathione transferase so as to can inhibit the hyperplasia of prostate and inflammation, and can prevent and cure prostatic carcinoma and skin carcinoma.

A photothermal therapeutic apparatus for treating prostatic diseases is composed of power supply system, laser system consisting of relay, power supply and laser device, computer control system, thermal radiation circuit, cables and therapeutic probe consisting of laser output window, temp sensor, thermal radiator, jacket and handle. Its advantages are high curative effect, no by-effect, compact structure and high stability.

The invention discloses an ilicis rotundae cortex medicament composition for preventing such diseases as prostatitis and prostatic hyperplasia. The composition is obtained through extraction from barks of llex rotunda thunb. and refinement and is characterized by being formed by pedunculoside, syringin, rotundic acid and other substances. Pharmacological tests prove that the composition has the effect of preventing prostatitis, prostatic hyperplasia and the like. The composition has new application to preparing medicaments for preventing prostatic diseases. Pharmaceutic preparations of the composition are elaborated and can be any one of tablets, capsules, pills, granules, suspensions, dripping pills, ointments and rectal administration preparations such as suppositories.

The invention relates to a medicament for treating prostatic diseases. The raw material drugs of the effective ingredients of the drug contain Wild Buckwheat Rhizome, Lighiyellow Sophora Root, Twisted-leaved Fritillary Bulbi, Herba Polygoni Avicularis, Semen Plantaginis, Psoralea corylifolia, Acruginous Turmeric Rhizome and Radix Cyathulae. The raw material drugs are properly processed and / or mixed with the excipients acceptable in pharmacy and prepared into various oral preparations and external preparations. The drugs of the invention has the efficacies of clearing heat and promoting diuresis, activating blood and relieving pain and is applicable to the medicament for treating prostatic diseases.

The invention relates to the technical field of health-care products, in particular to a phytosterol tablet. The phytosterol tablet is prepared from the following raw materials in weight ratio: 385.56 parts of phytosterol, 51 parts of dextrin, 32.64 parts of starch, 69.9 parts of sodium carboxymethyl starch, 104.04 parts of povidone, 12.38 parts of magnesium stearate and 2.45 parts of lactose, wherein the weight-average relative molecular weight of the povidone is 2000. A preparation method for the phytosterol tablet comprises the following steps of: evenly mixing all raw materials to obtain a mixture; spraying a mixed solution of an ethanol solution and a hydroxypropyl methylcellulose solution to moist the mixture; pelletizing; drying; performing intermediate inspection; performing granule shaping; and tableting. The phytosterol tablet has the advantages that the dissolving-out speed of the active principle is high; the dissolubility is high; the bioavailability is high; the action of the phytosterol can be better performed; and the medication cost is reduced. The phytosterol tablet is most effective in assisting on reducing blood fat, and meanwhile, also has effects of controlling prostatic diseases and regulating immunity and growth and has an anti-cancer effect, an anti-inflammatory effect and an antiviral effect.

The invention discloses an ultrasonic treatment unit for prostatic diseases, which comprises a spherical crown body, an ultrasonic probe arranged at the bottom of the spherical crown body, an installation base, a spherical crown body support, a spherical crown body support lifting mechanism, a spherical crown body support rotating mechanism, a spherical crown body swing mechanism and an ultrasonic probe lifting mechanism, wherein the spherical crown body support lifting mechanism is installed on the installation base, the spherical crown body support and the spherical crown body support rotating mechanism are installed on the spherical crown body support lifting mechanism, and the spherical crown body swing mechanism and the ultrasonic probe lifting mechanism are installed on the spherical crown body support. Through the linkage of the spherical crown body support lifting mechanism, the spherical crown body support rotating mechanism, the spherical crown body swing mechanism and a spherical crown body rotary mechanism, the spherical domain of the spherical crown body of the ultrasonic treatment unit for prostatic diseases is realized. The invention has the advantages that the structure is compact, the occupied area is small and great progress is made in the ultrasonic treatment unit for prostatic diseases.

The invention discloses a production process of prostatic disease treating particles. The production process comprises an extraction step and a preparation step, wherein the extraction step comprises the following specific steps of: picking each medicinal material, weighing each medicinal material according to parts by weight, and washing motherwort herb, polygonum aviculare and safflower which are required to be washed to a clean state in boiler batch in a spraying way with a medicament washing machine; and putting all of five medicinal materials belonging to the same extraction boiler batch into a multifunctional extraction tank for extracting to obtain a liquid medicament, sucking the liquid medicament into a single-effect vacuum concentrating tank, and concentrating in vacuum to obtain clear paste; and the preparation step comprises the following steps of: putting the weighed extract powder and rape bee pollen into a trough type mixing machine, mixing for 8-12 minutes, adding ethanol of which the volume concentration is 85 percent, stirring for 3-7 minutes, and preparing a soft material. The production process has the advantages of simple Chinese medicinal components, good extraction effect, mild reaction conditions and short reaction time. A preparation provided by the invention is used for treating prostatitis and prostatoplasia, and has a remarkable curative effect.

The invention relates to the medical health field, in particular to a pill for the treatment of prostatic diseases and a preparation method thereof. The pill for the treatment of the prostatic diseases is prepared from aristolochia cinnabarina, rhizoma cimicifugae, actinolite, dianthus superbus, juncus effusus, curcuma zedoary, radix aconiti carmichaeli, chingma abutilon seed, lindernia antipoda, honeycomb, indigo naturalis, radix stemonae, common fenugreek seeds, gorgon euryale seed, fiveleaf akebia fruits, paniculate swallowwort root, mulberry, semen cassiae, cassia twig, Chinese yam, poria cocos, cortex moutan, rhizoma anemarrhenae, fritillary, garden balsam stems, herba epimedii, radix angelica sinensis, shixiao powder and portulaca oleracea. The preparation method includes the following steps: taking all the materials, mixing all the materials evenly, decocting the materials with 6-10 fold water for 2-4 hours three times, mixing decocted fluid, filtering the fluid, collecting filtrate, concentrating the collected filtrate into extract, adding auxiliary materials or excipients used for forming a preparation, and preparing all the materials into the pill. The pill for the treatment of the prostatic diseases takes effects quickly, is convenient to take, and has no side effects.

An electro-hydraulic apparatus for treating prostatic disease is composed of electric pulse signal generator and electrically conductive tube. Said electric pulse signal generator has a main transformer with the primary winding connected via an isolating transformer to external power supply and the secondary winding via a voltage regulator to a jack to which said electrically conductive tube can be connected. Its advantages are high safety, high curative effect, use of LCD device, and regulatable energy output.

The present invention relates to novel methods and devices for detecting non-complexed prostate specific antigen (PSA), which can be used either alone or in conjunction with total PSA tests to identify patients having either benign prostatic diseases (BPD), such as benign prostatic hyperplasia, prostatitis, or glandular atrophy or prostatic adenocarcinoma (CAP). In a biological sample, one can find not only non-complexed PSA, but also PSA which has formed a complex with α1-antichymotrypsin (ACT). The present invention removes or precipitates complexed PSA (PSA-ACT) and ACT from a fluid sample, thereby removing any possible interference due to the binding of complexed PSA to assay reagents. The method requires contacting a biological fluid sample possibly containing a mixture of complexed PSA and non-complexed PSA either with an immuno-precipitating reagent or a device having attached an ACT specific binding partner which in both cases specifically binds only to ACT and the ACT portion of complexed PSA, thereby precipitating ACT and the bound complexed PSA and, thus, leaving any non-complexed PSA unbound and in solution. Then, the sample is measured for non-complexed PSA by means of a conventional specific binding reaction. The device can be a filter having a modified filter media that binds ACT and complexed PSA, while permitting the sample to flow or be pulled through the filter media and into assay reagents. Alternatively, the device can be a removable media that is placed into a sample, allowed to remain long enough to bind any ACT and complexed PSA present, and then withdrawn from the sample prior to running a PSA specific binding assay.

A therapeutic device for treating prostatic disease is composed of primary therapeutic unit, secondary theropeutic unit and electric pulse generator. The primary therapeutic unit is a band-shaped body with Pt electrode plate, permanent magnet and pulse electrode plate made of electrically conductive rubber. The pulse voltage generated by pulse generator is output via permanent magnet and pulse electrode plate. The negative DC voltage generated by high-voltage generator is output via Pt electrode plate. Its advantages are high curative effect, effectively killing pathogenic bacteria and virus, and improving internal secretion.

The present invention discloses a purification method of rape broken pollen and a prepared extract. The purification method includes using macroporous resin to accumulate the extract of rape broken pollen extracted by supercritical carbon dioxide, adopting ethanol for elution and collecting the eluent. The present invention is simple in the method and easy in operation. The extracted effective components have good anti-inflammatory activity and efficacy of resisting prostatic hyperplasia, prostatic fibrosis and other prostatic diseases.